The guanylyl cyclase activator YC-1 directly inhibits the voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells

Journal of Pharmacological Sciences

Volumn 112, Issue 1, 2010, Pages 64-72

  Park, Won Sun ^a   Ko, Jae Hong ^b   Ko, Eun A ^a   Son, Youn Kyoung ^c   Hong, Da Hye ^a   Jung, In Duk ^d   Park, Yeong Min ^d   Choi, Tae Hoon ^e   Kim, Nari ^a   Han, Jin ^a  

^a Inje University   (South Korea)

^b Chung Ang University   (South Korea)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d Pusan National University School of Medicine   (South Korea)

^e Andong Science College   (South Korea)

Author keywords

Coronary artery; Guanylyl cyclase; YC 1

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DISSOCIATION CONSTANT; DRUG MECHANISM; FEMALE; MALE; NONHUMAN; POTASSIUM CURRENT; RABBIT; SMOOTH MUSCLE FIBER; STEADY STATE; TIME;

EID: 75749085400     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09228FP     Document Type: Article

References (43)

1. Wohlfart P, Malinski T, Ruetten H, Schindler U, Linz W, Schoenafinger K, et al. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase. Br J Pharmacol. 1999;128:1316-1322.
2. Russwurm M, Behrends S, Harteneck C, Koesling D. Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochem J. 1998;335:125-130.
3. González-Luis G, Cogolludo A, Moreno L, Lodi F, Tamargo J, Pérez-vizcaíno F, et al. Relaxant effects of the soluble guanylate cyclase activator and NO sensitizer YC-1 in piglet pulmonary arteries. Biol Neonate. 2006;90:66-72.
4. Ko FN, Wu CC, Kuo SC, Lee FY, Teng CM. YC-1, a novel activator of platelet guanylate cyclase. Blood. 1994;84:4226-4233.
5. Mülsch A, Bauersachs J, Schäfer A, Stasch JP, Kast R, Busse R. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol. 1997;120:681-689.
6. Koesling D, Friebe A. Soluble guanylyl cyclase: structure and regulation. Rev Physiol Biochem Pharmacol. 1999;135:41-65.
7. Galle J, Zabel U, Hubner U, Hatzelmann A, Wagner B, Wanner C, et al. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Br J Pharmacol. 1999;127:195-203.
8. + channels in the relaxant effects of YC-1 in vascular smooth muscle. Eur J Pharmacol. 1999;382:11-18.
9. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995;268:C799-C822.
10. + current through a PKC-independent mechanism in isolated coronary arterial smooth muscle cells. J Cardiovasc Pharmacol. 2005b;45:260-269.
11. + current in rat intrapulmonary arterial myocytes by endothelin-1. Am J Physiol. 1998;274:L842-L853.
12. + currents. Biochem Biophys Res Commun. 2006;347:468-476.
13. Choi BH, Choi JS, Jeong SW, Hahn SJ, Yoon SH, Jo YH, et al. Direct block by bisindolylmaleimide of rat Kv1.5 expressed in Chinese hamster ovary cells. J Pharmacol Exp Ther. 2000;293:634-640.
14. + channels in coronary arterial smooth muscle cells. Life Sci. 2005;77:512-527.
15. Snyders DJ, Yeola SW. Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel. Circ Res. 1995;77:575-583.
16. Snyders DJ, Tamkun MM, Bennett PB. A rapidly activating and slowly inactivating potassium channel cloned from human heart. J Gen Physiol. 1993;101:513-543.
17. Roberds SL, Knoth KM, Po S, Blair TA, Bennett PB, Hartshorne RP, et al. Molecular biology of the voltage-gated potassium channels of the cardiovascular system. J Cardiovasc Electrophysiol. 1993;4:68-80.
18. Liu YC, Wu SN. Bay 41-2272, a potent activator of soluble guanylyl cyclase, stimulates calcium elevation and calcium-activated potassium current in pituitary GH 3 cells. Clin Exp Pharmacol Physiol. 2005;32:1078-1087.
19. Yeo EJ, Chun YS, Cho YS, Kim J, Lee JC, Kim MS, et al. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J Natl Cancer Inst. 2003;95:516-525.
20. + channel modulation in arterial smooth muscle. Acta Physiol Scand. 1998;164:549-557.
21. + channels in vascular smooth muscle cells. J Smooth Muscle Res. 2008;44:65-81.
22. + currents in smooth muscle cells isolated from human mesenteric arteries. J Physiol. 1992;457:431-454.
23. ATP channels by inhibiting steady-state protein kinase A activity and activating protein kinase Cε . J Physiol. 2001;530:193-205.
24. ATP channels in rabbit coronary and pulmonary arterial smooth muscle cells. J Cardiovasc Pharmacol. 2005;45:99-108.
25. Ledoux J, Warner ME, Brayden JE, Nelson MT. Calcium-activated potassium channels and the regulation of vascular tone. Physiology. 2006;21:69-78.
26. + channels in rabbit coronary arterial smooth muscle cells through protein kinase Cα. Biochem Biophys Res Commun. 2006;341:728-735.
27. + channels in cerebral artery smooth muscle cells. Am J Physiol. 1993;265:C299-C303.
28. + current in rabbit vascular smooth muscle cells. Am J Physiol. 1995;268:H926-H934.
29. ATP ) current in pig coronary vascular smooth muscle cells via a cyclic AMP-dependent protein kinase (PKA). J Physiol. 1998;507:117-129.
30. Son YK, Park WS, Ko JH, Han J, Kim NR, Earm YE. Protein kinase A-dependent activation of inward rectifier potassium channels by adenosine in rabbit coronary smooth muscle cells. Biochem Biophys Res Commun. 2005;337:1145-1152.
31. + currents of rat mesenteric arterial smooth muscle. Eur J Pharmacol. 2004;483:117-126.
32. v1.3 channels expressed in Chinese hamster ovary cells. Naunyn Schmiedebergs Arch Pharmacol. 1999;359:256-261.
33. v channels in rabbit coronary arterial smooth muscle cells. Biochem Biophys Res Commun. 2006;341:931-937.
34. Choi JS, Choi BH, Hahn SJ, Yoon SH, Min DS, Jo Y, et al. Inhibition of Kv1.3 channels by H-89 (N--[2-(p-bromocinnamylamino) ethyl]-5- isoquinolinesulfonamide) independent of protein kinase A. Biochem Pharmacol. 2001;61:1029-1032.
35. Choi BH, Choi JS, Rhie DJ, Yoon SH, Min DS, Jo YH, et al. Direct inhibition of the cloned Kv1.5 channel by AG-1478, a tyrosine kinase inhibitor. Am J Physiol. 2002;282:C1461-C1468.
36. Choi BH, Park JH, Hahn SJ. Open channel block of Kv3.1 currents by genistein, a tyrosine kinase inhibitor. Korean J Physiol Pharmacol. 2006;10:71-77.
37. + currents in cultured human pulmonary arterial smooth muscle cells. Br J Pharmacol. 2005;146:49-59.
38. Beech DJ, Bolton TB. Two components of potassium current activated by depolarization of single smooth muscle cells from the rabbit portal vein. J Physiol. 1989;418:293-309.
39. + currents from rabbit isolated aortic smooth muscle cells. Br J Pharmacol. 1995;116:3139-3148.
40. + current of rabbit vascular myocytes. Circ Res. 2001;89:1038-1044.
41. + current in rat mesenteric artery smooth muscle cells. Life Sci. 2002;71:1465-1473.
42. Carrier GO, Fuchs LC, Winecoff AP, Giulumian AD, White RE. Nitrovasodilators relax mesenteric microvessels by cGMP-induced stimulation of Ca-activated K channels. Am J Physiol. 1997;273:H76-H84.
43. Ca channels via cyclic AMP- and cyclic-dependent protein kinases by eugenosedin-A in rat basilar artery myocytes. Br J Pharmacol. 2007;152:374-385.